Study explores effects of metformin in obese children

Study explores effects of metformin in obese children

(HealthDay)—For obese hyperinsulinemic children, metformin seems to decrease perceived hunger and increase perceived fullness, according to a study published online Dec. 8 in Diabetes, Obesity and Metabolism.

Mopelola A. Adeyemo, M.P.H., from the National Institutes of Health in Bethesda, Md., and colleagues examined the effects of metformin on body weight and energy balance in 100 obese hyperinsulinemic aged 6 to 12 years. On two separate occasions the subjects ate ad libitum from standardized food arrays, before and after six months of study medication. The first test meal was consumed after an overnight fast, while a pre-meal load preceded the second meal. Data were available for 84 children (45 metformin-treated and 39 placebo-treated).

The researchers found that, independent of changes in body composition, metformin treatment correlated with significant reductions from baseline in the adjusted mean energy intake after the pre-meal load compared with placebo (metformin: −104.5 ± 83.8 kcal; placebo: +144.2 ± 96.9 kcal; P = 0.034). Following the pre-meal load, there was a significant decrease in ratings of hunger and an increase in ratings of fullness with metformin (P = 0.013 and 0.01, respectively).

"In conclusion, we found that the weight-loss effects of treatment may be related to its ability to reduce in obese, hyperinsulinemic children," the authors write. "Metformin's effects may thus be useful as an adjunct to diet, exercise, and behavioral therapy in the management of ."

One author disclosed financial ties to Pfizer.

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2014 HealthDay. All rights reserved.

Citation: Study explores effects of metformin in obese children (2014, December 18) retrieved 19 March 2024 from https://medicalxpress.com/news/2014-12-explores-effects-metformin-obese-children.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Continued metformin beneficial for diabetes with cirrhosis

 shares

Feedback to editors